British Journal of Clinical Pharmacology

Biomarkers and surrogate endpoints
pp. 491-494(4)
Author: Aronson, J. K.

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects
pp. 495-510(16)
Authors: Dumont, G. J. H.; de Visser, S. J.; Cohen, A. F.; van Gerven, J. M. A.

Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability
pp. 511-519(9)
Authors: Saez, Anabelle M. Opazo; Mosel, Frank; Nürnberger, Jens; Rushentsova, U.; Gössl, Mario; Mitchell, Anna; Schäfers, Rafael F.; Philipp, Thomas; Wenzel, René R.

Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients
pp. 520-523(4)
Authors: Davies, J.; Gavin, A.; Band, M.; Morris, A.; Struthers, A.

Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions
pp. 524-535(12)
Authors: Ladd, L. A.; Kam, P. C.; Williams, D. B.; Wright, A. W. E.; Smith, M. T.; Mather, L. E.

Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males
pp. 536-541(6)
Authors: Stass, H.; Kubitza, D.; Möller, J.-G.; Delesen, H.

Determination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers
pp. 542-545(4)
Authors: Al-Amoud, A. I.; Clark, B. J.; Assi, K. A.; Chrystyn, H.

Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx^® insulin Diabetes Management System
pp. 546-551(6)
Authors: McElduff, Aidan; Mather, Laurence E.; Kam, Peter C.; Clauson, Per

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism
pp. 552-563(12)
Authors: Shon, Ji-Hong; Yoon, Young-Ran; Kim, Min-Jung; Kim, Kyoung-Ah; Lim, Young-Chae; Liu, Kwang-Hyeon; Shin, Dong-Hoon; Lee, Chung Han; Cha, In-June; Shin, Jae-Gook

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
pp. 564-573(10)
Authors: Perreault, S.; Blais, L.; Lamarre, D.; Dragomir, A.; Berbiche, D.; Lalonde, L.; Laurier, C.; St-Maurice, F.; Collin, J.

Khat chewing is a risk factor for acute myocardial infarction: a case-control study
pp. 574-581(8)
Authors: Al-Motarreb, A.; Briancon, S.; Al-Jaber, N.; Al-Adhi, B.; Al-Jailani, F.; Salek, M S.; Broadley, K J.

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
pp. 582-587(6)
Authors: You, J. H. S.; Chan, F. W. H.; Wong, R. S. M.; Cheng, G.

Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial
pp. 588-592(5)
Authors: Altan-Yaycioglu, R.; Yaycioglu, O.; Aydin Akova, Y.; Guvel, S.; Ozkardes, H.

Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient
pp. 593-597(5)
Authors: Ikeda, Hiroaki; Murakami, Teruo; Takano, Mikihisa; Usui, Tsuguru; Kihira, Kenji

Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate
pp. 598-601(4)
Authors: Snell, Paul; Dave, Nisha; Wilson, Katie; Rowell, Lucy; Weil, Angelica; Galitz, Lawrence; Robson, Richard

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)
pp. 602-604(3)
Authors: Niemi, Mikko; Kivistö, Kari T.; Hofmann, Ute; Schwab, Matthias; Eichelbaum, Michel; Fromm, Martin F.

Handbook of Analytical Separations, Vol. 5: Drug Monitoring and Clinical Chemistry
pp. 605-605(1)

Statins, lack of energy and ubiquinone
pp. 606-607(2)
Author: Reidenberg, Marcus M.

Brugada-like ECG abnormalities during thioridazine overdose
pp. 608-608(1)
Authors: Copetti, R.; Proclemer, A.; Pillinini, P. P.

Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of October 8th 2004
pp. 609-623(15)

Proceedings of the British Pharmacological Society Clinical Pharmacology Section 14–16 December 2004
pp. 624-650(27)